Current Obesity Reports, Год журнала: 2025, Номер 14(1)
Опубликована: Фев. 12, 2025
Язык: Английский
Current Obesity Reports, Год журнала: 2025, Номер 14(1)
Опубликована: Фев. 12, 2025
Язык: Английский
Phytomedicine, Год журнала: 2025, Номер 138, С. 156382 - 156382
Опубликована: Янв. 13, 2025
Язык: Английский
Процитировано
0Pharmaceuticals, Год журнала: 2025, Номер 18(2), С. 193 - 193
Опубликована: Янв. 31, 2025
Berberine is a promising agent for modulating the intestinal microbiota, playing crucial role in human health homeostasis. This natural compound promotes growth of beneficial bacteria such as Bacteroides, Bifidobacterium, and Lactobacillus while reducing harmful Escherichia coli. Clinical preclinical studies demonstrate that helps regulate T2D metabolic disorders, improves blood glucose levels during T2D, reduces lipid profile chronic inflammation, especially when combined with probiotics. represents adjuvant therapy inflammatory diseases, particularly due to its multifaceted actions inhibiting proinflammatory cytokines pathways IBS, IBD, UC modulation gut microbiota and/or enhancement integrity epithelial barrier. review establishes basis future treatment protocols berberine fully elucidates mechanisms.
Язык: Английский
Процитировано
0Metabolism Open, Год журнала: 2025, Номер 25, С. 100352 - 100352
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Polymers for Advanced Technologies, Год журнала: 2025, Номер 36(2)
Опубликована: Фев. 1, 2025
ABSTRACT The objective of a regenerative medicine is to repair, restore, and regenerate tissues organs that occurred due injury or defect disease. Additionally, the purpose reverse aging process body by utilizing body's innate healing ability. There still significant venture needs be directed for advancement in arena medicine, which makes use products derived from cell therapy as well biomedical. Stem cells growth factors are primary components medicine; hence, novel drug delivering systems now being studied augment transport active pharmaceuticals. Lipid‐based complexed with therapeutics suited site‐specific controlled release. Lipids biocompatible available various sources molecular weights self‐assemble into forms hydrophilic hydrophobic parts. By enhancing plasma membrane fluidity, excipients such non‐ionic surfactants, fatty acids, glycerides increase permeability. Liposomes, nanoparticles, nano‐emulsions, micelles nano‐lipid carriers can improve bioavailability both lipophilic medicines. lipoidal‐polymeric had emerged promising multifaceted application cytocompatibility, ecofriendly, ability encapsulate variety drugs. Further, treatment biomedical tissue engineering, rapidly developing discipline. Furthermore, similar vein, delivery technologies combined stem promote engraftment, differentiation, survival. Hence colloidal carrier has impending versatile applications. Therefore, review offer an abridged information on significance technology offering confined ecosystem facilitates them thrive distinguish effective manner.
Язык: Английский
Процитировано
0Current Obesity Reports, Год журнала: 2025, Номер 14(1)
Опубликована: Фев. 12, 2025
Язык: Английский
Процитировано
0